期刊文献+

原发性鼻腔鼻窦黏膜恶性黑色素瘤4例临床病理分析 被引量:11

Primary sinonasal mucosal malignant melanoma:a clinicopathologic study of 4 cases
下载PDF
导出
摘要 目的探讨原发性鼻腔鼻窦黏膜恶性黑色素瘤(SMMM)的临床病理特点、鉴别诊断、治疗与预后。方法回顾性分析4例SMMM的临床病理资料,观察其组织形态特征及免疫组化特点,并复习相关文献。结果患者男性1例,女性3例,平均年龄75.5岁(65~90岁),临床主要表现为鼻塞、出血及鼻腔新生物,镜下瘤细胞形态多样,异型性较明显,以上皮样细胞和小圆细胞为主,伴有局部少量梭形细胞样细胞,仅部分显示黑色素。其中1例可见黏液样变,1例色素性黏膜恶性黑色素瘤局部复发后细胞体积明显增大,色素减少,多数细胞胞质透明,呈气球样变。免疫组化示HMB45、vimentin、S-100均不同程度(+),NSE、LCA、SMA、CD99和desmin(-),局部CK、CD68弱(+)各1例,Ki-67程度不一。结论鼻腔原发性黑色素瘤少见,恶性程度较高,形态多样,免疫组化对诊断及鉴别较为重要。 Objective To investigate the clinicopathologic characteristics,differential diagnosis,therapy and prognosis of primary sinonasal mucosal malignant melanoma.Methods With review of literature,the clinicolpathologic data were retrospectively analyzed while characteristics of morphology and immunohistochemisty of the tumor cells were observed in 4 patients with primary sinonasal mucosal malignant melanoma.Results The primary sinonasal mucosal malignant melanoma was diagnosed in 3 female patients and 1 male with mean age of 75.5(65-90) years.The clinical manifestation was nasal obstruction,epistaxis or neoplasm.Microscopically,the heteromorphism of the tumor cells was great and the morphologic features were various.The tumor consisted mainly of epithelioid cells and/or small round cells with local spindle cells.Melanin was noticed only in part of the cases and myxoid change was found in one case.Still we observed in one case that pigmented mucosal melanoma cells became bigger in size and hypopigmented with clear cytoplasm,so-called "balloon degeneration",after local recurrence.Immunohistochemisty showed that the tumor cells were all positive for HMB45,vimentin and S-100 protein in a varying degree,but NSE,LCA,SMA,CD99 and desmin negative,while focal and weak-positive expression of CK and CD68 was also noted in one cases,and Ki-67 expressied in a different level.Conclusion The primary sinonasal mucosal malignant melanoma is rare and highly heterogenous.The application of immunohistochemistry plays an important role in its diagnosis and differential diagnosis.
出处 《诊断病理学杂志》 CSCD 2011年第2期89-93,共5页 Chinese Journal of Diagnostic Pathology
关键词 鼻腔肿瘤 原发性黑色素瘤 免疫组化 Nasal tumor Primary melanoma Immunohistochemisty
  • 相关文献

参考文献17

  • 1Moreno MA, Roberts DB, Kupferman ME, et al. Mucosal melanoma of the nose and paranasal sinuses, a contemporary experience from the M. D. Anderson Cancer Center[ J]. Cancer, 2010,116(9) :2215 - 2223.
  • 2Barnes L.头颈部肿瘤病理学和遗传学[M].刘红刚译.京:人民卫生出版社,2006.80-82.
  • 3Christopher DM.Fletcher.肿瘤组织病理学诊断[M].回允中译.第3版.北京:北京大学医学出版社,2009.118-120.
  • 4Murali R, Loughman NT, McKenzie PR,et al. Cytologic features of metastatic and recurrent melanoma in patients with primary cutaneous desmoplastic melanoma[ J]. Am J Clin Pathol, 2008, 130(5) :715 -723.
  • 5Ara M, Maillo C, Martin R, et al. Recurrent lentigo maligna as amelanotic lentigo maligna melanoma[ j]. J Eur Acad Dermatol Venereo1,2002,16 (5) :506 - 510.
  • 6Narasimhan K, Kucuk O, Lin HS, et al. Sinonasal mucosal melanoma: a 13-year experience at a single institution [ J ]. Skull Base, 2009,19 ( 4 ) :255 - 262.
  • 7Chen N, Gong J, Chen X, et al. Cytokeratin expression in malignant melanoma: potential application of in-situ hybridization analysis of mRNA [ J ]. Melanoma Res, 2009,19 ( 2 ) :87 - 93.
  • 8Ladstein RG, Baehmann IM, Straume O,et al. Ki-67 expression is superior to mitotic count and novel proliferation markers PHH3, MCM4 and mitosin as a prognostic factor in thick cutaneous melanoma[ J]. BMC Cancer, 2010,14 (10) : 140.
  • 9Nonaka D,Chiriboga L, Rubin BP. Soxl0:a pan-schwannian and melanocytic marker[ J ]. Am J Surg Pathol, 2008,32 ( 9 ) : 1291 - 1298.
  • 10Takata M, Murata H, Saida T. Molecular pathogenesis of malignant melanoma: a different perspective from the studies of melanocytic nevus and acral melanoma [ J ]. Pigment Cell Melanoma Res,2010,23( 1 ) :64 -71.

二级参考文献10

  • 1Lassacher A,Worda M,Kaddu S,et al.T1799A BRAF muta-tion is common in PUVAlentigines[].Journal of Investigative Dermatology.2006
  • 2Thomas NE,Berwick M,Cordeiro-Stone M.Could BRAF muta-tions in melanocytic lesions arise from DNA damage induced byultraviolet radiation?[].Journal of Investigative Dermatology.2006
  • 3Montagut C,Settleman J.Targeting the RAF-MEK-ERKpathwayin cancer therapy[].Cancer Letters.2009
  • 4Tsai J,Lee JT,Wang W,et al.Discovery of a selective inhibitorof oncogenic B-Raf kinase with potent antimelanoma activity[].Proceedings of the National Academy of Sciences of the United States of America.2008
  • 5Davies H,Bignell GR,Cox C,et al.Mutations of the Braf gene in human cancer[].Nature.2002
  • 6Gray-Schopfer V,Wellbrock C,Marais R.Melanoma biology and new targeted therapy[].Nature.2007
  • 7ZHANG B H,GUAN K L.Activation of B-raf kinase requ iresphosphorylation of the conserved residues Thr598 and Ser601[].EMBO Journal.2000
  • 8Satyamoorthy,K,Li,G,Gerrero,MR,Brose,MS,Volpe,P.Constitutive mitogen-activated protein kinase activation in melanoma is mediated by both BRAF mutations and autocrine growth factor stimulation[].Cancer Research.2003
  • 9Cruz F 3rd,Rubin BP,Wilson D,et al.Absence of BRAF and NRAS mutations in uveal melanoma[].Cancer Research.2003
  • 10Maldonado JL,Fridlyand J,Patel H,et al.Determinants of BRAF mutations in primary melanomas[].Journal of the National Cancer Institute.2003

共引文献17

同被引文献74

引证文献11

二级引证文献32

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部